
Demis Hassabis Raises $5 Billion in His Quest to Solve All Disease
Isomorphic is developing its own drug pipeline while designing medicines with Lilly, Novartis and Johnson & Johnson, putting it alongside the pharma giants as both a research partner and a drug developer.














